MedPath

Long-term Follow-up Study of Substance Abuse Screening and Intervention in Multi Primary Care Centers

Not Applicable
Completed
Conditions
Substance Use
Interventions
Other: Intervention Group
Other: Control Group
Registration Number
NCT03452241
Lead Sponsor
Shanghai Mental Health Center
Brief Summary

The purpose of this research is to improve the ability of primary medical staffs in screening and intervention for alcohol, benzodiazepines, and other illicit drug use.

Detailed Description

In order to reduce the social and personal harm caused by drugs, it is urgent to strengthen the ability of the primary health institutions in screening and intervention the addictive substances use. Firstly, the investigators will invite 10 primary medical staffs and 10 experts in addition to revise the manual of Alcohol, Smoking, and Substance Use Involvement Screening Test (ASSIST) and Brief Intervention (BI). Then, the investigators will recruit related medical staffs in five provinces to participate the training of ASSIST and BI. Secondly, the researcher will investigate the effects of BI technology in reducing the use of addictive substances, improve the addiction related knowledge of patients through randomized controlled study. Finally, the investigators will collect the research information, revise the manual, and promote the training.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
480
Inclusion Criteria
  • aged 18-75 years;
  • the patient to the community medical institutions;
  • ASSIST score is in 12-27, in a moderate risk;
  • voluntary to participate;
  • to agree to complete baseline interviews and follow-up studies
Exclusion Criteria
  • unable to complete the questionnaire;
  • serious physical illness, action inconvenience.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention GroupIntervention GroupThe medical staffs who received the training will use the manual of brief intervention to deliver it and other materials about the harm of substance use.
Control GroupControl GroupThe participants only receive the materials about the harm of substance use
Intervention Group 1Intervention GroupThe medical staffs who received the training will use the manual of brief intervention twice to deliver it and other materials about the harm of substance use.
Primary Outcome Measures
NameTimeMethod
Change from baseline in risk behaviors at 1 and 3 monthbaseline, 1 and 3 month

Risk Behaviors will be measured by ASSIST questionnaire.

Secondary Outcome Measures
NameTimeMethod
Motivation measured by Pre-treatment Readiness Scalebaseline, 1 and 3 month

PRSS is a 5-point scale and the highest score at any stage represents the patient at this stage.

Anxiety measured by Self-Rating Anxiety Scale (SAS).baseline, 1 and 3 month

SDS contains 20 items. According to the Chinese norm results, the standard points of the cut-off value is 50 points, of which 50-59 is divided into mild anxiety, 60-69 is divided into moderate anxiety, 70 points for severe anxiety

Knowledge related to Substance Use measured by Knowledge related to Addiction questionnairebaseline, 1 and 3 month

Knowledge related to substance use will be measured by Knowledge related to Addiction questionnaire

Depression measured by Self-Rating Depression Scale (SDS)baseline, 1 and 3 month

SDS contains 20 items and the standard total score is 53, 53-62: mild to mild depression; 63-72: moderate to severe;\> 72: severe depression

Self-esteem measured by Self-esteem questionnairebaseline, 1 and 3 month

the change of self-esteem will be measured by Self-esteem questionnaire.

Positive and Negative Affect measured by Positive and Negative Affect Scale (PANAS)baseline, 1 and 3 month

It contains 20 entries. A high positive emotional score indicates an individual's energy, concentration, and emotional well-being while a low score indicates indifference. Negative emotional high points that the individual subjective feeling puzzled, painful emotional state, while the score is low that calm.

Trial Locations

Locations (1)

Henan Provincical Peoples Hospital

🇨🇳

Henan, China

© Copyright 2025. All Rights Reserved by MedPath